# Randomized Phase II Trial of Erlotinib Alone or With Carboplatin and Paclitaxel in Patients Who Were Never or Light Former Smokers With Advanced Lung Adenocarcinoma: CALGB 30406 Trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/randomized-phase-ii-trial-of-erlotinib-alone-or-with-carboplatin-and-paclitaxel/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Pasi A. Jänne,Xiaofei Wang,Mark A. Socinski,Jeffrey Crawford,Thomas E. Stinchcombe,Lin Gu,Marzia Capelletti,Martin J. Edelman,Miguel A. Villalona‐Calero,Robert A. Kratzke,Everett E. Vokes,Vincent A. Miller |
| Citations | 249 |
| DOI | 10.1200/jco.2011.40.1315 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2162394887 |
| PMID | 22547605 |
| Type | article |
| Year | 2012 |

## Paper authors

- [Martin J. Edelman](https://scholariq.org/researchers/martin-j-edelman/)

## Paper journal

- [Journal of Clinical Oncology](https://scholariq.org/journals/journal-of-clinical-oncology/)

## Paper primary topic

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

## Paper topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.